Project Grant RF1AG096921
Award Date 9/15/25
Completion Date 9/14/29
Dollars Obligated $2.5M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Alabama, USA
Similar Awards
- This $2,365,042 Project Grant was awarded by the National Institute on Aging (NIA) under the Aging Research Federal Grant Program (CFDA 93.866) to conduct research on the biological underpinnings of Alzheimer's disease and related dementias (ADRD). The research aims to better characterize the interplay between biological markers of neurodegeneration, vascular, nutritional, and inflammatory systems, and their interface with social and economic factors, by leveraging cross-national comparisons...
- This federal Project Grant award for $2,557,260 from the National Institute on Aging (CFDA 93.866 Aging Research program) will fund a study titled "Lifecourse Predictors and Mechanisms of Early Clinical ADRD among Black and White Adults in their Sixties". The study aims to investigate the transition from midlife to early late-life and identify the earliest manifestations of Alzheimer's disease (AD) and Alzheimer's disease-related disorders (ADRD) in a diverse population. The research...
- This $322,286 federal Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) supports research to advance health equity in the use of novel treatments for Alzheimer's disease and related dementias (ADRD). The primary objectives are to: Conduct focus groups with diverse individuals affected by ADRD to understand their medication decision-making processes. Design and administer discrete choice experiments to learn how different treatment attributes are...
- This Project Grant award from the National Institute on Aging (CFDA 93.866 Aging Research) in the amount of $297,000.00 will support a mixed methods study to understand the challenges and benefits of delivering new Alzheimer's disease (AD) drugs equitably to African American and white patients in Alabama. The objective is to assess access to care barriers, perceived value, and costs and benefits of new AD drugs for these two populations. In the initial R61 planning phase, the University of...
- This $1,933,556 Project Grant awarded by the National Institute on Aging (NIA) under its Aging Research program (CFDA 93.866) will support research to assess the impact of hospital-based health information technology (hospital-HIT) on healthcare quality and equity for patients with Alzheimer's disease and related dementias (ADRD). The primary awardee, the University of Maryland, College Park, will conduct a ten-year longitudinal study to evaluate how hospital-HIT systems that promote care...
- This Project Grant award of $4,787,820.00 from the National Institute on Aging (CFDA 93.866 - Aging Research) aims to gain a better understanding of the individual- and system-level characteristics that influence diagnosis of mild cognitive impairment (MCI) and Alzheimer's disease and related dementias (ADRD), and how diagnosis can moderate the effects of cognitive decline on employment, future care, and quality of life. The key objectives are to: 1) examine whether older adults experiencing...
- This $3,687,278 federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) aims to optimize the validity of comparative effectiveness research in Alzheimer's disease and related dementias using large language models. The grant supports research at Brigham & Women's Hospital, a subsidiary of the Partners Healthcare System, to build novel large language models that can extract clinically relevant phenotypes from electronic health record data. This will...
- This $2,497,615 federal Project Grant award, funded by the National Institute on Aging under the Aging Research program (CFDA 93.866), aims to evaluate the impact of new Medicare home health agency (HHA) payment policies on healthcare utilization and outcomes for Medicare beneficiaries with Alzheimer's disease and related dementias (ADRD). The project has three key objectives: 1) characterizing changes in the ADRD beneficiary population eligible for HHA services, 2) evaluating the effect of...
- This federal Project Grant award of $331,439 from the National Institute on Aging (CFDA 93.866 - Aging Research) supports a research project titled "Health Equity in Alzheimer's Treatment (HEAT)". The key objectives of the project are to: Use qualitative and quantitative methods to better understand the preferences, diagnostic/monitoring burden, and cost factors affecting the real-world effectiveness of new anti-amyloid Alzheimer's medications in predominantly Black and low-income...
- This Federal Project Grant award of $319,000 from the National Institute on Aging (CFDA 93.866 - Aging Research) to Brown University will examine rural-urban disparities in Alzheimer's disease and related dementias across the United States. The key products or services to be delivered under this 2-year award include: Producing novel and robust estimates of dementia prevalence in rural and urban areas of the U.S. Characterizing the types of rural places and people most affected by dementia. The...